The Plot Thickens At Amgen; Piper Still Overweight
March 16, 2016 at 15:25 PM EDT
Piper Jaffray said the Street is underestimating the implications of the lawsuit of Amgen, Inc. (NASDAQ: AMGN) against Regeneron ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.